Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bluebird Bio
Bluebird Bio
Just in time to assure a decision before CVR deadline, Bristol Myers Squibb files NDA for Celgene/bluebird CAR-T
Endpoints
Tue, 03/31/20 - 10:47 am
Bristol-Meyers Squibb
CAR-T
Celgene
ide-cel
Bluebird Bio
liso-cel
ozanimod
Bluebird says gene therapy application delayed again, citing disagreement with FDA
BioPharma Dive
Thu, 03/26/20 - 11:57 pm
Bluebird Bio
LentiGlobin
FDA
Why AnaptysBio, bluebird bio, and Exelixis Shares Rebounded Last Friday
Motley Fool
Mon, 03/16/20 - 10:31 am
pharma stocks
AnaptysBio
Bluebird Bio
Exelixis
COVID-19
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
Sun, 02/23/20 - 06:17 pm
beta thalassemia
rare disease
drug development
Acceleron
Bristol-Myers Squibb
Bluebird Bio
Sangamo Therapeutics
Vertex Pharmaceuticals
Editas Medicine
Syros Pharmaceuticals
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
Motley Fool
Wed, 02/19/20 - 09:51 am
Bluebird Bio
earnings
CAR-T tackles multiple myeloma by using the target CD229 to kill cancer stem cells
Fierce Biotech
Mon, 02/10/20 - 10:11 am
CAR-T
Multiple Myeloma
CD229
JNJ
Bluebird Bio
5 biopharmas to watch as the decade's last earnings kick off
BioPharma Dive
Wed, 01/22/20 - 11:06 am
earnings
Novartis
Biogen
Eli Lilly
Global Blood Therapeutics
Bluebird Bio
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
LentiGlobin gene therapy for sickle cell on course for filing, says bluebird
Pharmaforum
Wed, 12/11/19 - 09:50 pm
LentiGlobin
Bluebird Bio
sickle cell disease
Myeloma cell therapies, now in pharma hands, move into spotlight
Biopharma Dive
Sat, 12/7/19 - 11:47 pm
ASH2019
cell therapies
Multiple Myeloma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Reuters
Wed, 11/27/19 - 12:36 pm
gene therapy
drug manufacturing
Pfizer
Novartis
Bluebird Bio
PTC Therapeutics
Krystal Biotech
Bluebird gets European green light for gene therapy production
Biopharma Dive
Fri, 10/25/19 - 10:34 am
Bluebird Bio
gene therapy
Europe
Zynteglo
Why Novo Nordisk should buy Uniqure
EP Vantage
Fri, 10/11/19 - 10:31 am
Novo Nordisk
gene editing
hemophilia
uniQure
Bluebird Bio
Novo taps bluebird bio for gene-editing tech
Fierce Biotech
Wed, 10/9/19 - 09:43 am
Novo Nordisk
Bluebird Bio
R&D
gene editing
hemophilia
bluebird presents long-term data from CALD gene therapy
Pharmaforum
Fri, 09/20/19 - 09:28 am
Bluebird Bio
gene therapy
cALD
Lenti-D
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
bluebird bio Prepares for Launch
Motley Fool
Thu, 08/8/19 - 10:22 am
Bluebird Bio
Zynteglo
beta-thalassemia
drug launches
Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates
Yahoo/Zacks.com
Fri, 08/2/19 - 11:46 pm
Bluebird Bio
earnings
Where Will bluebird bio Be in 1 Year?
Motley Fool
Fri, 06/21/19 - 09:58 am
Bluebird Bio
bb2121
Zynteglo
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »